Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation (EAST-AF) trial.
暂无分享,去创建一个
W. Shimizu | Y. Egami | A. Kobori | M. Horie | Takeshi Kimura | T. Morimoto | I. Morishima | S. Shizuta | S. Kamakura | T. Noda | K. Satomi | T. Ozawa | T. Yao | Makoto Ito | K. Nakai | H. Fujimoto | K. Kusano | M. Masuda | Koichi Inoue | T. Haruna | Tetsuya Watanabe | T. Shirayama | Koji Miyamoto | Y. Furukawa | K. Kaitani | T. Kawaji | Fumiharu Miura | T. Nishida | Y. Nakazawa | T. Toyota | Yukei Higashi | K. Okajima | T. Kurotobi | M. Yahata | M. Naito | Mariko Tanaka | T. Yoshizawa | Hiroaki Sugiyama | Tetsuma Kawaji | Katsunori Okajima | Masaki Naito
[1] Hakan Oral,et al. Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation , 2002, Circulation.
[2] Frank Bogun,et al. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. , 2009, Journal of the American College of Cardiology.
[3] J. Svendsen,et al. Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial). , 2014, European heart journal.
[4] M. Weir,et al. The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .
[5] T. Tanabe,et al. Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms: a multicenter, randomized, placebo-controlled,double-blind study (J-BAF Study). , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[6] M. Orii,et al. A randomized study on the efficacy of intravenous cibenzoline and pilsicainide administered prior to electrical cardioversion in patients with lone paroxysmal and persistent atrial fibrillation. , 2009, Journal of cardiology.
[7] K. Okumura,et al. Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008) : Digest Version , 2010 .
[8] Hakan Oral,et al. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. , 2002, Journal of the American College of Cardiology.
[9] M. Allessie,et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.
[10] T. Tanabe,et al. Dose-Response Effects of Bepridil in Patients With Persistent Atrial Fibrillation Monitored With Transtelephonic Electrocardiograms , 2009 .
[11] Y. Iesaka,et al. Electrical Connections Between Pulmonary Veins: Implication for Ostial Ablation of Pulmonary Veins in Patients With Paroxysmal Atrial Fibrillation , 2002, Circulation.
[12] W. Shimizu,et al. Three-month lower-dose flecainide after catheter ablation of atrial fibrillation. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[13] S. Yusuf,et al. Dabigatran Versus Warfarin: Effects on Ischemic and Hemorrhagic Strokes and Bleeding in Asians and Non-Asians With Atrial Fibrillation , 2013, Stroke.
[14] Panos Vardas,et al. The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association. , 2014, European heart journal.
[15] H. Otsuka. Current Status of Clinical Study in Japan(How to Make Japanese Original Evidence in Cardiology, The 69th Annual Scientific Meeting of the Japanese Circulation Society) , 2005 .
[16] Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013). , 2014, Circulation journal : official journal of the Japanese Circulation Society.
[17] D. Horiuchi,et al. Randomized crossover study of the long-term effects of pilsicainide and cibenzoline in preventing recurrence of symptomatic paroxysmal atrial fibrillation: influence of the duration of arrhythmia before therapy. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[18] H. Daida,et al. Conversion and maintenance of sinus rhythm by bepridil in patients with persistent atrial fibrillation. , 2005, Circulation journal : official journal of the Japanese Circulation Society.
[19] W. Rogers,et al. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.
[20] Liang-ping Zhao,et al. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial. , 2014, European heart journal.
[21] T. Gunji,et al. Appropriate dosing of antiarrhythmic drugs in Japan requires therapeutic drug monitoring * , 2005, Journal of clinical pharmacy and therapeutics.
[22] Gerhard Hindricks,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[23] T. Mittal,et al. The ESC Committee for Practice Guidelines (CPG). , 2013, European heart journal.
[24] A. Russo,et al. Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study): Six-Month Follow-Up Study , 2011, Circulation. Arrhythmia and electrophysiology.
[25] Daniel Steven,et al. Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans. , 2008, Journal of the American College of Cardiology.
[26] J. McMurray,et al. Increased mortality after dronedarone therapy for severe heart failure. , 2008, The New England journal of medicine.
[27] Elia Biganzoli,et al. Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation. Arrhythmia and electrophysiology.
[28] E. Quin. Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study) , 2010 .
[29] S. Mouly,et al. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. , 2006, Archives of internal medicine.
[30] Jeroen J. Bax,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.
[31] J. Bourke,et al. Delayed cure despite early recurrence after pulmonary vein isolation for atrial fibrillation. , 2003, The American journal of cardiology.